2012 | Aarkstore.com | Isis pharmaceuticals, inc. – product pipeline review – 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “Isis Pharmaceuticals, Inc. - Product
Pipeline Review - 2012” provides data on the Isis Pharmaceuticals, Inc.’s research
and development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Isis Pharmaceuticals, Inc.’s corporate website, SEC filings,
investor presentations and featured press releases, both from Isis Pharmaceuticals,
Inc. and industry-specific third party sources, put together by Global Markets
Direct’s team.
Scope
- Isis Pharmaceuticals, Inc. - Brief Isis Pharmaceuticals, Inc. overview including
business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Isis Pharmaceuticals, Inc. human therapeutic
division.
- Overview of pipeline therapeutics across various therapy areas.
Reasons to buy

2. - Evaluate Isis Pharmaceuticals, Inc.’s strategic position with total access to detailed
information on its product pipeline.
- Assess the growth potential of Isis Pharmaceuticals, Inc. in its therapy areas of
focus.
- Identify new drug targets and therapeutic classes in the Isis Pharmaceuticals, Inc.’s
R&D portfolio and develop key strategic initiatives to reinforce pipeline in those
areas.
Table of contents:
List of Tables 6
List of Figures 7
Isis Pharmaceuticals, Inc. Snapshot 8
Isis Pharmaceuticals, Inc. Overview 8
Key Information 8
Key Facts 8
Isis Pharmaceuticals, Inc. – Research and Development Overview 9
Key Therapeutic Areas 9
Isis Pharmaceuticals, Inc. – Pipeline Review 12
Pipeline Products by Stage of Development 12
Pipeline Products – Monotherapy 13
Pipeline Products – Combination Treatment Modalities 14
Isis Pharmaceuticals, Inc. – Pipeline Products Glance 15
Isis Pharmaceuticals, Inc. Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
Isis Pharmaceuticals, Inc. – Early Stage Pipeline Products 17
Pre-Clinical Products/Combination Treatment Modalities 17
Isis Pharmaceuticals, Inc. – Drug Profiles 18
ISIS 113715 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ISIS-APOA 20
Product Description 20
Mechanism of Action 20

3. List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012
Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
IntelGenx Corp. – Product Pipeline Review – 2012
Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012
JADO Technologies GmbH – Product Pipeline Review – 2012
Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2012
NeuroSearch A/S – Product Pipeline Review – 2012
NovaDel Pharma, Inc. – Product Pipeline Review – 2012
Portola Pharmaceuticals, Inc. – Product Pipeline Review – 2012

4. Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com